{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T22:24:40Z","timestamp":1759616680067,"version":"3.41.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:italic>Acinetobacter baumannii<\/jats:italic> is one of the most dangerous opportunistic pathogens in the global health care setup. Its drug resistance and biofilm-forming capability are often associated with chronic infections that are difficult to treat. Therefore, the clinical treatments for highly drug-resistant <jats:italic>A. baumannii<\/jats:italic> are limited. Antimicrobial peptides are broad-spectrum antibacterial agents combined with antibiotics that minimize selective bacterial resistance and enhance antibacterial efficacy. The current study evaluated the synergistic antibacterial activities of clinically important peptide antibiotics combined with other antimicrobials against nine extensively drug-resistant <jats:italic>A. baumannii<\/jats:italic> strains in planktonic and biofilm cells <jats:italic>in vitro<\/jats:italic>. Polymyxin B and E combined with imipenem showed 100% synergy in the planktonic cell with the checkerboard. Moreover, polymyxin E with rifampicin and bacitracin with imipenem or meropenem showed 100% additive effects. In the biofilm cell, polymyxin B and E combined with azithromycin showed 100% synergy, when vancomycin with azithromycin, rifampicin, and bacitracin with azithromycin or rifampicin, and teicoplanin with tigecycline or rifampicin, all showed 100% additive effects. Therefore, peptide antibiotics combined with other antimicrobials have synergistic or additive effects on extensively drug-resistant <jats:italic>A. baumannii<\/jats:italic> in planktonic and biofilm cells. In addition, the combination of polymyxins with carbapenems or azithromycin could be an ideal therapy against extensively drug-resistant <jats:italic>A. baumannii<\/jats:italic> infections.<\/jats:p>","DOI":"10.3389\/fphar.2022.890955","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T08:12:42Z","timestamp":1652256762000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["In Vitro Activity of Peptide Antibiotics in Combination With Other Antimicrobials on Extensively Drug-Resistant Acinetobacter baumannii in the Planktonic and Biofilm Cell"],"prefix":"10.3389","volume":"13","author":[{"given":"Qianlin","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baodong","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00181-19","article-title":"Antimicrobial Resistance in ESKAPE Pathogens","volume":"33","author":"De Oliveira","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1016\/j.jcot.2019.10.002","article-title":"Effects of Powdered Rifampin and Vancomycin Solutions on Biofilm Production of staphylococcus Aureus on Orthopedic Implants","volume":"11","author":"Douthit","year":"2020","journal-title":"J. Clin. Orthop. Trauma"},{"key":"B3","doi-asserted-by":"publisher","first-page":"44922","DOI":"10.1007\/s11356-020-10989-5","article-title":"Bacteriocin-a Potential Antimicrobial Peptide towards Disrupting and Preventing Biofilm Formation in the Clinical and Environmental Locales","volume":"27","author":"Duraisamy","year":"2020","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/ja.2014.107","article-title":"Resistance to Rifampicin: a Review","volume":"67","author":"Goldstein","year":"2014","journal-title":"J. Antibiot. (Tokyo)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1198-743X.2004.00856.x","article-title":"False Synergy between Vancomycin and Beta-Lactams against Glycopeptide-Intermediate Staphylococcus aureus (GISA) Caused by Inappropriate Testing Methods","volume":"10","author":"Goldstein","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"B6","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.cmi.2015.11.004","article-title":"Laboratory Diagnosis, Clinical Management and Infection Control of the Infections Caused by Extensively Drug-Resistant Gram-Negative Bacilli: a Chinese Consensus Statement","volume":"22","author":"Guan","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"B7","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/bph.15291","article-title":"Zafirlukast Is a Broad-Spectrum Thiol Isomerase Inhibitor that Inhibits Thrombosis without Altering Bleeding Times","volume":"178","author":"Holbrook","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e002132","DOI":"10.1128\/jcm.00213-21","article-title":"Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition","volume":"59","author":"Humphries","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fmicb.2014.00178","article-title":"Antivirulence Activity of Azithromycin in Pseudomonas aeruginosa","volume":"5","author":"Imperi","year":"2014","journal-title":"Front. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"104700","DOI":"10.1016\/j.micpath.2020.104700","article-title":"Synergistic Effect of Two Antimicrobial Peptides, Nisin and P10 with Conventional Antibiotics against Extensively Drug-Resistant Acinetobacter Baumannii and Colistin-Resistant Pseudomonas aeruginosa Isolates","volume":"150","author":"Jahangiri","year":"2021","journal-title":"Microb. Pathog."},{"key":"B11","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1128\/cmr.00056-05","article-title":"Peptide Antimicrobial Agents","volume":"19","author":"Jenssen","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10040414","article-title":"Sub-Inhibitory Concentrations of Ciprofloxacin Alone and Combinations with Plant-Derived Compounds against P. aeruginosa Biofilms and Their Effects on the Metabolomic Profile of P. aeruginosa Biofilms","volume":"10","author":"Kart","year":"2021","journal-title":"Antibiot. (Basel)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s42003-020-0803-x","article-title":"How Do Bacterial Membranes Resist Polymyxin Antibiotics?","volume":"3","author":"Khondker","year":"2020","journal-title":"Commun. Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1089\/mdr.2014.0236","article-title":"Biofilm Formation and Colistin Susceptibility of Acinetobacter Baumannii Isolated from Korean Nosocomial Samples","volume":"21","author":"Kim","year":"2015","journal-title":"Microb. Drug Resist"},{"key":"B15","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nrmicro.2017.99","article-title":"Targeting Microbial Biofilms: Current and Prospective Therapeutic Strategies","volume":"15","author":"Koo","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fcimb.2017.00055","article-title":"Biology of Acinetobacter Baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options","volume":"7","author":"Lee","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jmii.2013.05.007","article-title":"Synergy of Imipenem\/colistin Methanesulfonate Combinations against Imipenem-Nonsusceptible Multidrug-Resistant Acinetobacter Baumannii","volume":"47","author":"Leu","year":"2014","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12879-021-05963-6","article-title":"Combination Inhibition Activity of Chlorhexidine and Antibiotics on Multidrug-Resistant Acinetobacter Baumannii In Vitro","volume":"21","author":"Lin","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1016\/j.ultrasmedbio.2016.03.016","article-title":"Low-Frequency Ultrasound Enhances Antimicrobial Activity of Colistin-Vancomycin Combination against Pan-Resistant Biofilm of Acinetobacter Baumannii","volume":"42","author":"Liu","year":"2016","journal-title":"Ultrasound Med. Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, Extensively Drug-Resistant and Pandrug-Resistant Bacteria: an International Expert Proposal for Interim Standard Definitions for Acquired Resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1046\/j.1365-2958.2003.03786.x","article-title":"Cell Wall Stress Responses in Bacillus Subtilis: the Regulatory Network of the Bacitracin Stimulon","volume":"50","author":"Mascher","year":"2003","journal-title":"Mol. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0238195","DOI":"10.1371\/journal.pone.0238195","article-title":"Propranolol, Chlorpromazine and Diclofenac Restore Susceptibility of Extensively Drug-Resistant (XDR)-Acinetobacter Baumannii to Fluoroquinolones","volume":"15","author":"Mohammed","year":"2020","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","article-title":"Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review","volume":"10","author":"Mulani","year":"2019","journal-title":"Front. Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.2147\/idr.S199993","article-title":"Effects of Sub-inhibitory Concentrations of Meropenem and Tigecycline on the Expression of Genes Regulating Pili, Efflux Pumps and Virulence Factors Involved in Biofilm Formation by Acinetobacter Baumannii","volume":"12","author":"Navidifar","year":"2019","journal-title":"Infect. Drug Resist"},{"key":"B25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jgar.2018.11.016","article-title":"Colistin Monotherapy versus Colistin\/rifampicin Combination Therapy in Pneumonia Caused by Colistin-Resistant Acinetobacter Baumannii: A Randomised Controlled Trial","volume":"17","author":"Park","year":"2019","journal-title":"J. Glob. Antimicrob. Resist"},{"key":"B26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.pharmthera.2014.03.003","article-title":"Azithromycin: Mechanisms of Action and Their Relevance for Clinical Applications","volume":"143","author":"Parnham","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"18097","DOI":"10.1038\/s41598-020-75218-y","article-title":"In Vitro activity of Biofilm Inhibitors in Combination with Antibacterial Drugs against Extensively Drug-Resistant Acinetobacter Baumannii","volume":"10","author":"Peng","year":"2020","journal-title":"Sci. Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1128\/jb.00017-16","article-title":"Antibiofilm Peptides: Potential as Broad-Spectrum Agents","volume":"198","author":"Pletzer","year":"2016","journal-title":"J. Bacteriol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0162576","DOI":"10.1371\/journal.pone.0162576","article-title":"Differences in Biofilm Mass, Expression of Biofilm-Associated Genes, and Resistance to Desiccation between Epidemic and Sporadic Clones of Carbapenem-Resistant Acinetobacter Baumannii Sequence Type 191","volume":"11","author":"Selasi","year":"2016","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9110817","article-title":"Biofilm-Induced Antibiotic Resistance in Clinical Acinetobacter Baumannii Isolates","volume":"9","author":"Shenkutie","year":"2020","journal-title":"Antibiot. (Basel)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1080\/14712598.2017.1315402","article-title":"An Overview of Antimicrobial Peptides and the Latest Advances in Their Development","volume":"17","author":"Sierra","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2174\/1874285801711010053","article-title":"Understanding the Mechanism of Bacterial Biofilms Resistance to Antimicrobial Agents","volume":"11","author":"Singh","year":"2017","journal-title":"Open Microbiol. J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.34171\/mjiri.34.24","article-title":"Pan Drug-Resistant Acinetobacter Baumannii Causing Nosocomial Infections Among Burnt Children","volume":"34","author":"Sobouti","year":"2020","journal-title":"Med. J. Islam Repub. Iran."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1097\/ccm.0000000000001029","article-title":"Combination Therapy for Extreme Drug-Resistant Acinetobacter Baumannii: Ready for Prime Time?","volume":"43","author":"Spellberg","year":"2015","journal-title":"Crit. Care Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/s1473-3099(17)30753-3","article-title":"Discovery, Research, and Development of New Antibiotics: the WHO Priority List of Antibiotic-Resistant Bacteria and Tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"D1087","DOI":"10.1093\/nar\/gkv1278","article-title":"APD3: the Antimicrobial Peptide Database as a Tool for Research and Education","volume":"44","author":"Wang","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.3389\/fmicb.2020.01919","article-title":"Synergistic Potential of Antimicrobial Combinations against Methicillin-Resistant Staphylococcus aureus","volume":"11","author":"Yu","year":"2020","journal-title":"Front. Microbiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.890955\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T08:12:50Z","timestamp":1652256770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.890955\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":37,"alternative-id":["10.3389\/fphar.2022.890955"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.890955","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"article-number":"890955"}}